Enterprise Financial Services Corp Abiomed Inc Transaction History

Enterprise Financial Services Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$310.19 - $376.2 $17,991 - $21,819	-58 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$262.71 - $351.17 $4,991 - $6,672	19 Added 48.72%	58 $18,000
Q2 2020 Aug 04, 2020	SELL	$141.4 - $257.09 $282 - $514	-2 Reduced 4.88%	39 $9,000
Q1 2020 May 15, 2020	BUY	$130.51 - $196.01 $4,045 - $6,076	31 Added 310.0%	41 $6,000
Q3 2019 Oct 31, 2019	SELL	$175.89 - $279.23 $1,583 - $2,513	-9 Reduced 47.37%	10 $2,000
Q2 2019 Jul 30, 2019	BUY	$250.96 - $284.94 $2,258 - $2,564	9 Added 90.0%	19 $5,000
Q4 2018 Jan 25, 2019	SELL	$281.08 - $444.25 $4,216 - $6,663	-15 Reduced 60.0%	10 $3,000
Q3 2018 Oct 26, 2018	BUY	$354.53 - $449.75 $5,317 - $6,746	15 Added 150.0%	25 $11,000
Q3 2017 Oct 27, 2017	BUY	$145.39 - $168.6 $1,453 - $1,686	10	10 $2,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.